Home/Pipeline/HCV Project

HCV Project

Hepatitis C virus infection

Pre-clinicalActive

Key Facts

Indication
Hepatitis C virus infection
Phase
Pre-clinical
Status
Active
Company

About Pomona Ricerca

Pomona Ricerca is an Italian biotech firm with a dual-focused business model combining proprietary R&D and fee-for-service commercial activities. Its core R&D strategy involves cloning and characterizing human broadly neutralizing antibodies against viruses like HCV, HIV, Influenza A, and JC virus, with the aim of out-licensing therapeutic candidates at the pre-clinical stage or developing epitope-based vaccines. The company also generates revenue by marketing high-quality antibodies and proteins and offering custom antibody/protein services to other biotech and pharmaceutical entities. With a strong IP portfolio and international collaborations, Pomona positions itself as a partner for advancing novel infectious disease therapeutics.

View full company profile

Therapeutic Areas

Other Hepatitis C virus infection Drugs

DrugCompanyPhase
Hepatitis C Antiviral CombinationsNatco PharmaLaunched